The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Intravitreal Injection Market Research Report 2025
Synopsis
Intravitreal injection is a drug that is injected directly into the vitreous cavity of the eye and is mainly used to treat various fundus diseases.
The global Intravitreal Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Intravitreal Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Intravitreal Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Intravitreal Injection include Sanofi, Novartis, Bayer, Genentech, Apellis Pharmaceuticals, Inc., Coherus BioSciences Inc., Iveric Bio
, Regeneron and Roche, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Intravitreal Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravitreal Injection.
Report Scope
The Intravitreal Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intravitreal Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravitreal Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Novartis
Bayer
Genentech
Apellis Pharmaceuticals, Inc.
Coherus BioSciences Inc.
Iveric Bio
Regeneron
Roche
Qilu Pharmaceutical Co.,Ltd.
Chengdu Kanghong Pharmaceutical Group
Segment by Type
Ranibizumab
Bevacizumab
Aflibercept
Brolucizumab
Faricimab
Others
Segment by Application
Diabetic Eye Disease
AMD
Retinal Vein Occlusion
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intravitreal Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intravitreal Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Intravitreal injection is a drug that is injected directly into the vitreous cavity of the eye and is mainly used to treat various fundus diseases.
The global Intravitreal Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Intravitreal Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Intravitreal Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Intravitreal Injection include Sanofi, Novartis, Bayer, Genentech, Apellis Pharmaceuticals, Inc., Coherus BioSciences Inc., Iveric Bio
, Regeneron and Roche, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Intravitreal Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravitreal Injection.
Report Scope
The Intravitreal Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intravitreal Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravitreal Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Novartis
Bayer
Genentech
Apellis Pharmaceuticals, Inc.
Coherus BioSciences Inc.
Iveric Bio
Regeneron
Roche
Qilu Pharmaceutical Co.,Ltd.
Chengdu Kanghong Pharmaceutical Group
Segment by Type
Ranibizumab
Bevacizumab
Aflibercept
Brolucizumab
Faricimab
Others
Segment by Application
Diabetic Eye Disease
AMD
Retinal Vein Occlusion
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intravitreal Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intravitreal Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Intravitreal Injection Market Overview
1.1 Product Overview and Scope of Intravitreal Injection
1.2 Intravitreal Injection Segment by Type
1.2.1 Global Intravitreal Injection Market Value Comparison by Type (2024-2030)
1.2.2 Ranibizumab
1.2.3 Bevacizumab
1.2.4 Aflibercept
1.2.5 Brolucizumab
1.2.6 Faricimab
1.2.7 Others
1.3 Intravitreal Injection Segment by Application
1.3.1 Global Intravitreal Injection Market Value by Application: (2024-2030)
1.3.2 Diabetic Eye Disease
1.3.3 AMD
1.3.4 Retinal Vein Occlusion
1.3.5 Others
1.4 Global Intravitreal Injection Market Size Estimates and Forecasts
1.4.1 Global Intravitreal Injection Revenue 2019-2030
1.4.2 Global Intravitreal Injection Sales 2019-2030
1.4.3 Global Intravitreal Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Intravitreal Injection Market Competition by Manufacturers
2.1 Global Intravitreal Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Intravitreal Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Intravitreal Injection Average Price by Manufacturers (2019-2024)
2.4 Global Intravitreal Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Intravitreal Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intravitreal Injection, Product Type & Application
2.7 Intravitreal Injection Market Competitive Situation and Trends
2.7.1 Intravitreal Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Intravitreal Injection Players Market Share by Revenue
2.7.3 Global Intravitreal Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Intravitreal Injection Retrospective Market Scenario by Region
3.1 Global Intravitreal Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Intravitreal Injection Global Intravitreal Injection Sales by Region: 2019-2030
3.2.1 Global Intravitreal Injection Sales by Region: 2019-2024
3.2.2 Global Intravitreal Injection Sales by Region: 2025-2030
3.3 Global Intravitreal Injection Global Intravitreal Injection Revenue by Region: 2019-2030
3.3.1 Global Intravitreal Injection Revenue by Region: 2019-2024
3.3.2 Global Intravitreal Injection Revenue by Region: 2025-2030
3.4 North America Intravitreal Injection Market Facts & Figures by Country
3.4.1 North America Intravitreal Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Intravitreal Injection Sales by Country (2019-2030)
3.4.3 North America Intravitreal Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Intravitreal Injection Market Facts & Figures by Country
3.5.1 Europe Intravitreal Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Intravitreal Injection Sales by Country (2019-2030)
3.5.3 Europe Intravitreal Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Intravitreal Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Intravitreal Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Intravitreal Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Intravitreal Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Intravitreal Injection Market Facts & Figures by Country
3.7.1 Latin America Intravitreal Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Intravitreal Injection Sales by Country (2019-2030)
3.7.3 Latin America Intravitreal Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intravitreal Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Intravitreal Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Intravitreal Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Intravitreal Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Intravitreal Injection Sales by Type (2019-2030)
4.1.1 Global Intravitreal Injection Sales by Type (2019-2024)
4.1.2 Global Intravitreal Injection Sales by Type (2025-2030)
4.1.3 Global Intravitreal Injection Sales Market Share by Type (2019-2030)
4.2 Global Intravitreal Injection Revenue by Type (2019-2030)
4.2.1 Global Intravitreal Injection Revenue by Type (2019-2024)
4.2.2 Global Intravitreal Injection Revenue by Type (2025-2030)
4.2.3 Global Intravitreal Injection Revenue Market Share by Type (2019-2030)
4.3 Global Intravitreal Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Intravitreal Injection Sales by Application (2019-2030)
5.1.1 Global Intravitreal Injection Sales by Application (2019-2024)
5.1.2 Global Intravitreal Injection Sales by Application (2025-2030)
5.1.3 Global Intravitreal Injection Sales Market Share by Application (2019-2030)
5.2 Global Intravitreal Injection Revenue by Application (2019-2030)
5.2.1 Global Intravitreal Injection Revenue by Application (2019-2024)
5.2.2 Global Intravitreal Injection Revenue by Application (2025-2030)
5.2.3 Global Intravitreal Injection Revenue Market Share by Application (2019-2030)
5.3 Global Intravitreal Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Intravitreal Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Intravitreal Injection Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Intravitreal Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novartis Intravitreal Injection Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Corporation Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Intravitreal Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bayer Intravitreal Injection Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 Genentech
6.4.1 Genentech Corporation Information
6.4.2 Genentech Description and Business Overview
6.4.3 Genentech Intravitreal Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Genentech Intravitreal Injection Product Portfolio
6.4.5 Genentech Recent Developments/Updates
6.5 Apellis Pharmaceuticals, Inc.
6.5.1 Apellis Pharmaceuticals, Inc. Corporation Information
6.5.2 Apellis Pharmaceuticals, Inc. Description and Business Overview
6.5.3 Apellis Pharmaceuticals, Inc. Intravitreal Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Apellis Pharmaceuticals, Inc. Intravitreal Injection Product Portfolio
6.5.5 Apellis Pharmaceuticals, Inc. Recent Developments/Updates
6.6 Coherus BioSciences Inc.
6.6.1 Coherus BioSciences Inc. Corporation Information
6.6.2 Coherus BioSciences Inc. Description and Business Overview
6.6.3 Coherus BioSciences Inc. Intravitreal Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Coherus BioSciences Inc. Intravitreal Injection Product Portfolio
6.6.5 Coherus BioSciences Inc. Recent Developments/Updates
6.7 Iveric Bio
6.6.1 Iveric Bio
Corporation Information
6.6.2 Iveric Bio
Description and Business Overview
6.6.3 Iveric Bio
Intravitreal Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Iveric Bio
Intravitreal Injection Product Portfolio
6.7.5 Iveric Bio
Recent Developments/Updates
6.8 Regeneron
6.8.1 Regeneron Corporation Information
6.8.2 Regeneron Description and Business Overview
6.8.3 Regeneron Intravitreal Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Regeneron Intravitreal Injection Product Portfolio
6.8.5 Regeneron Recent Developments/Updates
6.9 Roche
6.9.1 Roche Corporation Information
6.9.2 Roche Description and Business Overview
6.9.3 Roche Intravitreal Injection Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Roche Intravitreal Injection Product Portfolio
6.9.5 Roche Recent Developments/Updates
6.10 Qilu Pharmaceutical Co.,Ltd.
6.10.1 Qilu Pharmaceutical Co.,Ltd. Corporation Information
6.10.2 Qilu Pharmaceutical Co.,Ltd. Description and Business Overview
6.10.3 Qilu Pharmaceutical Co.,Ltd. Intravitreal Injection Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Qilu Pharmaceutical Co.,Ltd. Intravitreal Injection Product Portfolio
6.10.5 Qilu Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.11 Chengdu Kanghong Pharmaceutical Group
6.11.1 Chengdu Kanghong Pharmaceutical Group Corporation Information
6.11.2 Chengdu Kanghong Pharmaceutical Group Intravitreal Injection Description and Business Overview
6.11.3 Chengdu Kanghong Pharmaceutical Group Intravitreal Injection Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Chengdu Kanghong Pharmaceutical Group Intravitreal Injection Product Portfolio
6.11.5 Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intravitreal Injection Industry Chain Analysis
7.2 Intravitreal Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intravitreal Injection Production Mode & Process
7.4 Intravitreal Injection Sales and Marketing
7.4.1 Intravitreal Injection Sales Channels
7.4.2 Intravitreal Injection Distributors
7.5 Intravitreal Injection Customers
8 Intravitreal Injection Market Dynamics
8.1 Intravitreal Injection Industry Trends
8.2 Intravitreal Injection Market Drivers
8.3 Intravitreal Injection Market Challenges
8.4 Intravitreal Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Intravitreal Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Intravitreal Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Intravitreal Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Intravitreal Injection Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Intravitreal Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Intravitreal Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Intravitreal Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Intravitreal Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Intravitreal Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Intravitreal Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Intravitreal Injection, Product Type & Application
Table 12. Global Key Manufacturers of Intravitreal Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Intravitreal Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravitreal Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Intravitreal Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Intravitreal Injection Sales by Region (2019-2024) & (K Units)
Table 18. Global Intravitreal Injection Sales Market Share by Region (2019-2024)
Table 19. Global Intravitreal Injection Sales by Region (2025-2030) & (K Units)
Table 20. Global Intravitreal Injection Sales Market Share by Region (2025-2030)
Table 21. Global Intravitreal Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Intravitreal Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Intravitreal Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Intravitreal Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Intravitreal Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Intravitreal Injection Sales by Country (2019-2024) & (K Units)
Table 27. North America Intravitreal Injection Sales by Country (2025-2030) & (K Units)
Table 28. North America Intravitreal Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Intravitreal Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Intravitreal Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Intravitreal Injection Sales by Country (2019-2024) & (K Units)
Table 32. Europe Intravitreal Injection Sales by Country (2025-2030) & (K Units)
Table 33. Europe Intravitreal Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Intravitreal Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Intravitreal Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Intravitreal Injection Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Intravitreal Injection Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Intravitreal Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Intravitreal Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Intravitreal Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Intravitreal Injection Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Intravitreal Injection Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Intravitreal Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Intravitreal Injection Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Intravitreal Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Intravitreal Injection Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Intravitreal Injection Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Intravitreal Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Intravitreal Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Intravitreal Injection Sales (K Units) by Type (2019-2024)
Table 51. Global Intravitreal Injection Sales (K Units) by Type (2025-2030)
Table 52. Global Intravitreal Injection Sales Market Share by Type (2019-2024)
Table 53. Global Intravitreal Injection Sales Market Share by Type (2025-2030)
Table 54. Global Intravitreal Injection Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Intravitreal Injection Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Intravitreal Injection Revenue Market Share by Type (2019-2024)
Table 57. Global Intravitreal Injection Revenue Market Share by Type (2025-2030)
Table 58. Global Intravitreal Injection Price (US$/Unit) by Type (2019-2024)
Table 59. Global Intravitreal Injection Price (US$/Unit) by Type (2025-2030)
Table 60. Global Intravitreal Injection Sales (K Units) by Application (2019-2024)
Table 61. Global Intravitreal Injection Sales (K Units) by Application (2025-2030)
Table 62. Global Intravitreal Injection Sales Market Share by Application (2019-2024)
Table 63. Global Intravitreal Injection Sales Market Share by Application (2025-2030)
Table 64. Global Intravitreal Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Intravitreal Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Intravitreal Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Intravitreal Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Intravitreal Injection Price (US$/Unit) by Application (2019-2024)
Table 69. Global Intravitreal Injection Price (US$/Unit) by Application (2025-2030)
Table 70. Sanofi Corporation Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Intravitreal Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Sanofi Intravitreal Injection Product
Table 74. Sanofi Recent Developments/Updates
Table 75. Novartis Corporation Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis Intravitreal Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Novartis Intravitreal Injection Product
Table 79. Novartis Recent Developments/Updates
Table 80. Bayer Corporation Information
Table 81. Bayer Description and Business Overview
Table 82. Bayer Intravitreal Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Bayer Intravitreal Injection Product
Table 84. Bayer Recent Developments/Updates
Table 85. Genentech Corporation Information
Table 86. Genentech Description and Business Overview
Table 87. Genentech Intravitreal Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Genentech Intravitreal Injection Product
Table 89. Genentech Recent Developments/Updates
Table 90. Apellis Pharmaceuticals, Inc. Corporation Information
Table 91. Apellis Pharmaceuticals, Inc. Description and Business Overview
Table 92. Apellis Pharmaceuticals, Inc. Intravitreal Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Apellis Pharmaceuticals, Inc. Intravitreal Injection Product
Table 94. Apellis Pharmaceuticals, Inc. Recent Developments/Updates
Table 95. Coherus BioSciences Inc. Corporation Information
Table 96. Coherus BioSciences Inc. Description and Business Overview
Table 97. Coherus BioSciences Inc. Intravitreal Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Coherus BioSciences Inc. Intravitreal Injection Product
Table 99. Coherus BioSciences Inc. Recent Developments/Updates
Table 100. Iveric Bio
Corporation Information
Table 101. Iveric Bio
Description and Business Overview
Table 102. Iveric Bio
Intravitreal Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Iveric Bio
Intravitreal Injection Product
Table 104. Iveric Bio
Recent Developments/Updates
Table 105. Regeneron Corporation Information
Table 106. Regeneron Description and Business Overview
Table 107. Regeneron Intravitreal Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Regeneron Intravitreal Injection Product
Table 109. Regeneron Recent Developments/Updates
Table 110. Roche Corporation Information
Table 111. Roche Description and Business Overview
Table 112. Roche Intravitreal Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Roche Intravitreal Injection Product
Table 114. Roche Recent Developments/Updates
Table 115. Qilu Pharmaceutical Co.,Ltd. Corporation Information
Table 116. Qilu Pharmaceutical Co.,Ltd. Description and Business Overview
Table 117. Qilu Pharmaceutical Co.,Ltd. Intravitreal Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Qilu Pharmaceutical Co.,Ltd. Intravitreal Injection Product
Table 119. Qilu Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 120. Chengdu Kanghong Pharmaceutical Group Corporation Information
Table 121. Chengdu Kanghong Pharmaceutical Group Description and Business Overview
Table 122. Chengdu Kanghong Pharmaceutical Group Intravitreal Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Chengdu Kanghong Pharmaceutical Group Intravitreal Injection Product
Table 124. Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Intravitreal Injection Distributors List
Table 128. Intravitreal Injection Customers List
Table 129. Intravitreal Injection Market Trends
Table 130. Intravitreal Injection Market Drivers
Table 131. Intravitreal Injection Market Challenges
Table 132. Intravitreal Injection Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Intravitreal Injection
Figure 2. Global Intravitreal Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Intravitreal Injection Market Share by Type in 2023 & 2030
Figure 4. Ranibizumab Product Picture
Figure 5. Bevacizumab Product Picture
Figure 6. Aflibercept Product Picture
Figure 7. Brolucizumab Product Picture
Figure 8. Faricimab Product Picture
Figure 9. Others Product Picture
Figure 10. Global Intravitreal Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global Intravitreal Injection Market Share by Application in 2023 & 2030
Figure 12. Diabetic Eye Disease
Figure 13. AMD
Figure 14. Retinal Vein Occlusion
Figure 15. Others
Figure 16. Global Intravitreal Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Intravitreal Injection Market Size (2019-2030) & (US$ Million)
Figure 18. Global Intravitreal Injection Sales (2019-2030) & (K Units)
Figure 19. Global Intravitreal Injection Average Price (US$/Unit) & (2019-2030)
Figure 20. Intravitreal Injection Report Years Considered
Figure 21. Intravitreal Injection Sales Share by Manufacturers in 2023
Figure 22. Global Intravitreal Injection Revenue Share by Manufacturers in 2023
Figure 23. The Global 5 and 10 Largest Intravitreal Injection Players: Market Share by Revenue in 2023
Figure 24. Intravitreal Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 25. Global Intravitreal Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 26. North America Intravitreal Injection Sales Market Share by Country (2019-2030)
Figure 27. North America Intravitreal Injection Revenue Market Share by Country (2019-2030)
Figure 28. United States Intravitreal Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Canada Intravitreal Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Europe Intravitreal Injection Sales Market Share by Country (2019-2030)
Figure 31. Europe Intravitreal Injection Revenue Market Share by Country (2019-2030)
Figure 32. Germany Intravitreal Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. France Intravitreal Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. U.K. Intravitreal Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Italy Intravitreal Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Netherlands Intravitreal Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Asia Pacific Intravitreal Injection Sales Market Share by Region (2019-2030)
Figure 38. Asia Pacific Intravitreal Injection Revenue Market Share by Region (2019-2030)
Figure 39. China Intravitreal Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Japan Intravitreal Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. South Korea Intravitreal Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. India Intravitreal Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Southeast Asia Intravitreal Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. China Taiwan Intravitreal Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Australia Intravitreal Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Intravitreal Injection Sales Market Share by Country (2019-2030)
Figure 47. Latin America Intravitreal Injection Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Intravitreal Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Intravitreal Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Intravitreal Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Intravitreal Injection Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Intravitreal Injection Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Intravitreal Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Intravitreal Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. UAE Intravitreal Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Intravitreal Injection by Type (2019-2030)
Figure 57. Global Revenue Market Share of Intravitreal Injection by Type (2019-2030)
Figure 58. Global Intravitreal Injection Price (US$/Unit) by Type (2019-2030)
Figure 59. Global Sales Market Share of Intravitreal Injection by Application (2019-2030)
Figure 60. Global Revenue Market Share of Intravitreal Injection by Application (2019-2030)
Figure 61. Global Intravitreal Injection Price (US$/Unit) by Application (2019-2030)
Figure 62. Intravitreal Injection Value Chain
Figure 63. Intravitreal Injection Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
